LabCorp Acquiring Cholesterol Tester LipoScience

By | September 25, 2014

Scalper1 News

Medical-testing giant Laboratory Corp. of America (LH) agreed to buy startup LipoScience (LPDX) for $85.3 million in cash Thursday, sending the latter’s shares up more than 62% in the stock market today. LipoScience makes a lipid profile test using nuclear magnetic resonance technology to measure a patient’s cholesterol levels and help manage heart disease. The stock went public at 9 in January 2013, but was hammered for over a year, bottoming out Scalper1 News

Scalper1 News